Contact

All Stories

  1. Polyethylenimine-coated superparamagnetic iron oxide nanoparticles impair in vitro and in vivo angiogenesis

    Article • Nanomedicine Nanotechnology Biology and Medicine, October 2019, Elsevier

    Dr. Vladimir Mulens-Arias

  2. Disturbance of adhesomes by gold nanoparticles reveals a size- and cell type-bias

    Article • Biomaterials Science, January 2019, Royal Society of Chemistry

    Dr. Vladimir Mulens-Arias

  3. Polyethyleneimine-assisted one-pot synthesis of quasi-fractal plasmonic gold nanocomposites as a photothermal theranostic agent

    Article • Nanoscale, January 2019, Royal Society of Chemistry

    Dr. Vladimir Mulens-Arias

  4. Theranostic Iron Oxide Nanoparticle Cargo Defines Extracellular Vesicle-Dependent Modulation of Macrophage Activation and Migratory Behavior

    Article • Advanced Biosystems, July 2018, Wiley

    Dr. Vladimir Mulens-Arias

  5. Immunologic Response Elicited in Breast Cancer Patients Receiving a NeuGcGM3-based Vaccine as Adjuvant Therapy

    Article • Journal of Immunotherapy, October 2017, Wolters Kluwer Health

    Dr. Vladimir Mulens-Arias

  6. Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion

    Article • Nanomedicine Nanotechnology Biology and Medicine, May 2016, Elsevier

    Dr. Vladimir Mulens-Arias

  7. We dissect an unexpected anti-cancer property of polyethylenimine-coated iron oxide nanoparticles.

    Article • Journal of Controlled Release, October 2015, Elsevier

    Dr. Vladimir Mulens-Arias

  8. Polyethylenimine-coated SPIONs trigger macrophage activation through TLR-4 signaling and ROS production and modulate podosome dynamics

    Article • Biomaterials, June 2015, Elsevier

    Dr. Vladimir Mulens-Arias

  9. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery

    Article • Journal of Leukocyte Biology, January 2015, Wiley

    Dr. Vladimir Mulens-Arias

  10. PI3K p110δ Is Expressed by gp38−CD31+ and gp38+CD31+ Spleen Stromal Cells and Regulates Their CCL19, CCL21, and LTβR mRNA Levels

    Article • PLoS ONE, August 2013, PLOS

    Dr. Vladimir Mulens-Arias

  11. Development of Magnetic Nanoparticles for Cancer Gene Therapy: A Comprehensive Review

    Article • ISRN Nanomaterials, January 2013, Hindawi Publishing Corporation

    Dr. Vladimir Mulens-Arias

  12. Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients.

    Article • Human Vaccines, September 2010, Taylor & Francis

    Dr. Vladimir Mulens-Arias

  13. 2110 POSTER Active specific immunotherapy with NGcGM3/ VSSP/ Montanide ISA-51 (CIMAVaxG) vaccine in the treatment of patients with metastatic breast cancer: Results of a randomized phase II clinical trial

    Article • European Journal of Cancer Supplements, September 2007, Elsevier

    Dr. Vladimir Mulens-Arias